MYP_171141
Idarucizumab
Hemostasis
▸
Anticoagulant activity
Standard
225 amino acids
C1065H1645N271O334S5
Standard
QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC
23749.39 Da
8.89
4.88
4.45
0.0217
-0.05
0.62
0.14
36.26
76.62
0.1067
46870.00
47120.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0140565
VERIFIED: NO
Provenance & Taxonomy
Cricetulus griseus [Animal]
Monoclonal antibody
10029
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Disulfide-bonded therapeutic scaffold described in source text
Bio-Activity Profile
Coagulation factor replacement
Anticoagulant
CHO
initial half-life: 47 minutes terminal half-life: 10.3 h